Past Conference
Explore key agenda highlights, top speakers, and industry insights from the 2026 Conference.
Conference Co-Chairs
Alexandra Chambers
Senior Market Access Manager
Bayer
Farah Jivraj
Head of Market Access, Policy and Stakeholder Relations
Biogen Canada
Keynote Speaker
Tijana Fazlagic
Executive Director, Therapeutic Assessment & Access
BC Ministry of Health
Featured Speakers
Alex Haines
Director, Health Economics
Canada’s Drug Agency
Guillaume Couillard
Director General
Patented Medicine Prices Review Board (PMPRB)
Andrea Ladouceur
President & Chief Executive Officer
Bioscience Association Manitoba
Ursula Mann
Principal and Chief Patient Officer
Patient Voice Partners
Mina Tadrous
Assistant Professor, Leslie Dan Faculty of Pharmacy
University of Toronto
Key Topics
Global and Cross-Border Forces Shaping Canada’s Pharma Landscape
Analyzing international influences – from MFN policies and import tariffs to global pricing trends – and how Canada can strengthen its pharmaceutical leadership and market access strategy.
National and Provincial Policy Alignment in Market Access
Exploring how federal and provincial frameworks – such as National Pharmacare, PMPRB reforms, and provincial access programs – shape pricing, reimbursement, and access across Canada.
Data, Equity, and Patient-Centered Access Strategies
Focusing on using real-world data, patient engagement, and equity-focused design to improve drug accessibility, including lessons from Ozempic and rare disease programs.
Collaboration Across Stakeholders: Public, Private, and Industry
Highlighting operational and strategic collaboration among payers, regulators, and pharmaceutical leaders to streamline processes, reduce barriers, and enhance patient outcomes.
Download Brochure
Flip through our past conference brochure and discover the hot topics discussed.